Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Viral Conjunctivitis Pipeline Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact

3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies
5.1 Starpharma Holdings Ltd.
5.1.1 Starpharma Holdings Ltd. Company Profile
5.1.2 Starpharma Holdings Ltd. Business Overview
5.1.3 Starpharma Holdings Ltd. Viral Conjunctivitis Pipeline Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Starpharma Holdings Ltd. Viral Conjunctivitis Pipeline Drugs Products Introduction
5.2 Marinomed Biotechnologie GmbH
5.2.1 Marinomed Biotechnologie GmbH Company Profile
5.2.2 Marinomed Biotechnologie GmbH Business Overview
5.2.3 Marinomed Biotechnologie GmbH Viral Conjunctivitis Pipeline Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Marinomed Biotechnologie GmbH Viral Conjunctivitis Pipeline Drugs Products Introduction
5.3 NovaBay Pharmaceuticals, Inc.
5.3.1 NovaBay Pharmaceuticals, Inc. Company Profile
5.3.2 NovaBay Pharmaceuticals, Inc. Business Overview
5.3.3 NovaBay Pharmaceuticals, Inc. Viral Conjunctivitis Pipeline Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 NovaBay Pharmaceuticals, Inc. Viral Conjunctivitis Pipeline Drugs Products Introduction
5.4 NanoViricides, Inc.
5.4.1 NanoViricides, Inc. Company Profile
5.4.2 NanoViricides, Inc. Business Overview
5.4.3 NanoViricides, Inc. Viral Conjunctivitis Pipeline Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 NanoViricides, Inc. Viral Conjunctivitis Pipeline Drugs Products Introduction
5.5 NicOx S.A.
5.5.1 NicOx S.A. Company Profile
5.5.2 NicOx S.A. Business Overview
5.5.3 NicOx S.A. Viral Conjunctivitis Pipeline Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 NicOx S.A. Viral Conjunctivitis Pipeline Drugs Products Introduction
5.6 Adenovir Pharma AB
5.6.1 Adenovir Pharma AB Company Profile
5.6.2 Adenovir Pharma AB Business Overview
5.6.3 Adenovir Pharma AB Viral Conjunctivitis Pipeline Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Adenovir Pharma AB Viral Conjunctivitis Pipeline Drugs Products Introduction
5.7 Panoptes Pharma GES.M.B.H.
5.7.1 Panoptes Pharma GES.M.B.H. Company Profile
5.7.2 Panoptes Pharma GES.M.B.H. Business Overview
5.7.3 Panoptes Pharma GES.M.B.H. Viral Conjunctivitis Pipeline Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Panoptes Pharma GES.M.B.H. Viral Conjunctivitis Pipeline Drugs Products Introduction
5.8 Shire plc
5.8.1 Shire plc Company Profile
5.8.2 Shire plc Business Overview
5.8.3 Shire plc Viral Conjunctivitis Pipeline Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Shire plc Viral Conjunctivitis Pipeline Drugs Products Introduction
5.9 Allergan plc
5.9.1 Allergan plc Company Profile
5.9.2 Allergan plc Business Overview
5.9.3 Allergan plc Viral Conjunctivitis Pipeline Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Allergan plc Viral Conjunctivitis Pipeline Drugs Products Introduction
5.10 Novartis AG
5.10.1 Novartis AG Company Profile
5.10.2 Novartis AG Business Overview
5.10.3 Novartis AG Viral Conjunctivitis Pipeline Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Novartis AG Viral Conjunctivitis Pipeline Drugs Products Introduction

6 Market Analysis and Forecast, By Product Types
6.1 Global Viral Conjunctivitis Pipeline Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Viral Conjunctivitis Pipeline Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Viral Conjunctivitis Pipeline Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Viral Conjunctivitis Pipeline Drugs Price by Types (2015-2020)
6.2 Global Viral Conjunctivitis Pipeline Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Viral Conjunctivitis Pipeline Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Viral Conjunctivitis Pipeline Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Viral Conjunctivitis Pipeline Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Viral Conjunctivitis Pipeline Drugs Sales, Price and Growth Rate of FST-100
6.3.2 Global Viral Conjunctivitis Pipeline Drugs Sales, Price and Growth Rate of APD-209
6.4 Global Viral Conjunctivitis Pipeline Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 FST-100 Market Revenue and Sales Forecast (2020-2025)
6.4.2 APD-209 Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications
7.1 Global Viral Conjunctivitis Pipeline Drugs Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Viral Conjunctivitis Pipeline Drugs Sales and Market Share by Applications (2015-2020)
7.1.2 Global Viral Conjunctivitis Pipeline Drugs Revenue and Market Share by Applications (2015-2020)
7.2 Global Viral Conjunctivitis Pipeline Drugs Market Forecast by Applications (2020-2025)
7.2.1 Global Viral Conjunctivitis Pipeline Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Viral Conjunctivitis Pipeline Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Viral Conjunctivitis Pipeline Drugs Revenue, Sales and Growth Rate of Hospitals (2015-2020)
7.3.2 Global Viral Conjunctivitis Pipeline Drugs Revenue, Sales and Growth Rate of Clinics (2015-2020)
7.3.3 Global Viral Conjunctivitis Pipeline Drugs Revenue, Sales and Growth Rate of Others (2015-2020)
7.4 Global Viral Conjunctivitis Pipeline Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Hospitals Market Revenue and Sales Forecast (2020-2025)
7.4.2 Clinics Market Revenue and Sales Forecast (2020-2025)
7.4.3 Others Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions
8.1 Global Viral Conjunctivitis Pipeline Drugs Sales by Regions (2015-2020)
8.2 Global Viral Conjunctivitis Pipeline Drugs Market Revenue by Regions (2015-2020)
8.3 Global Viral Conjunctivitis Pipeline Drugs Market Forecast by Regions (2020-2025)

9 North America Viral Conjunctivitis Pipeline Drugs Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Viral Conjunctivitis Pipeline Drugs Market Sales and Growth Rate (2015-2020)
9.3 North America Viral Conjunctivitis Pipeline Drugs Market Revenue and Growth Rate (2015-2020)
9.4 North America Viral Conjunctivitis Pipeline Drugs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Viral Conjunctivitis Pipeline Drugs Market Analysis by Country
9.6.1 U.S. Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate
9.6.2 Canada Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate
9.6.3 Mexico Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate

10 Europe Viral Conjunctivitis Pipeline Drugs Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Viral Conjunctivitis Pipeline Drugs Market Sales and Growth Rate (2015-2020)
10.3 Europe Viral Conjunctivitis Pipeline Drugs Market Revenue and Growth Rate (2015-2020)
10.4 Europe Viral Conjunctivitis Pipeline Drugs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Viral Conjunctivitis Pipeline Drugs Market Analysis by Country
10.6.1 Germany Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate
10.6.2 United Kingdom Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate
10.6.3 France Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate
10.6.4 Italy Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate
10.6.5 Spain Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate
10.6.6 Russia Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate

11 Asia-Pacific Viral Conjunctivitis Pipeline Drugs Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Viral Conjunctivitis Pipeline Drugs Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Viral Conjunctivitis Pipeline Drugs Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Viral Conjunctivitis Pipeline Drugs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Viral Conjunctivitis Pipeline Drugs Market Analysis by Country
11.6.1 China Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate
11.6.2 Japan Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate
11.6.3 South Korea Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate
11.6.4 Australia Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate
11.6.5 India Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate

12 South America Viral Conjunctivitis Pipeline Drugs Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Viral Conjunctivitis Pipeline Drugs Market Sales and Growth Rate (2015-2020)
12.3 South America Viral Conjunctivitis Pipeline Drugs Market Revenue and Growth Rate (2015-2020)
12.4 South America Viral Conjunctivitis Pipeline Drugs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Viral Conjunctivitis Pipeline Drugs Market Analysis by Country
12.6.1 Brazil Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate
12.6.2 Argentina Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate
12.6.3 Columbia Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate

13 Middle East and Africa Viral Conjunctivitis Pipeline Drugs Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Viral Conjunctivitis Pipeline Drugs Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Viral Conjunctivitis Pipeline Drugs Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Viral Conjunctivitis Pipeline Drugs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Viral Conjunctivitis Pipeline Drugs Market Analysis by Country
13.6.1 UAE Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate
13.6.2 Egypt Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate
13.6.3 South Africa Viral Conjunctivitis Pipeline Drugs Sales and Growth Rate

14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 Appendix
15.1 Methodology
15.2 Research Data Source